Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
RESEARCH TOOLSreports
Takeda Pharmaceutical Company (TAK) Stock Price & Analysis
1,190 Followers
TAK Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.58 - $16.39
Previous Close$13.44
Volume2.67M
Average Volume (3M)1.49M
Market Cap
$43.01B
Enterprise Value$70.76B
Total Cash (Recent Filing)¥457.80B
Total Debt (Recent Filing)¥4.84T
Price to Earnings (P/E)42.2
Beta0.33
Next Earnings
Jul 31, 2024EPS Estimate
$0.12Last Dividend Ex-Date
Mar 27, 2024Dividend Yield4.18%
Share Statistics
EPS (TTM)0.32
Shares Outstanding3,137,776,702
10 Day Avg. Volume1,809,570
30 Day Avg. Volume1,488,643
Standard Deviation0.07
R-Squared0.18
Alpha-0.00503
Financial Highlights & Ratios
Price to Book (P/B)-0.01
Price to Sales (P/S)0.01
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$20.00Price Target Upside49.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Takeda Pharmaceutical Company News
PremiumCompany Announcements
Takeda Issues $500M Senior Note Due 2034
PremiumCompany Announcements
Takeda Shareholders Approve Dividends and Directors
PremiumCompany Announcements
Takeda Advances Sustainable Pharma Innovation
Ownership Overview
0.00%
Insiders
0.45% Mutual Funds
0.14% Other Institutional Investors
99.41% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TAK FAQ
What was Takeda Pharmaceutical Company’s price range in the past 12 months?
Takeda Pharmaceutical Company lowest stock price was $12.57 and its highest was $16.39 in the past 12 months.
What is Takeda Pharmaceutical Company’s market cap?
Currently, no data Available
When is Takeda Pharmaceutical Company’s upcoming earnings report date?
Takeda Pharmaceutical Company’s upcoming earnings report date is Jul 31, 2024 which is in 10 days.
How were Takeda Pharmaceutical Company’s earnings last quarter?
Takeda Pharmaceutical Company released its earnings results on May 09, 2024. The company reported -$0.007 earnings per share for the quarter, missing the consensus estimate of $0.003 by -$0.01.
Is Takeda Pharmaceutical Company overvalued?
According to Wall Street analysts Takeda Pharmaceutical Company’s price is currently Undervalued.
Does Takeda Pharmaceutical Company pay dividends?
Takeda Pharmaceutical Company pays a Semiannually dividend of $0.3 which represents an annual dividend yield of 4.18%. See more information on Takeda Pharmaceutical Company dividends here
What is Takeda Pharmaceutical Company’s EPS estimate?
Takeda Pharmaceutical Company’s EPS estimate is $0.12.
How many shares outstanding does Takeda Pharmaceutical Company have?
Takeda Pharmaceutical Company has 3,181,875,200 shares outstanding.
What happened to Takeda Pharmaceutical Company’s price movement after its last earnings report?
Takeda Pharmaceutical Company reported an EPS of -$0.007 in its last earnings report, missing expectations of $0.003. Following the earnings report the stock price went up 2.374%.
Which hedge fund is a major shareholder of Takeda Pharmaceutical Company?
Among the largest hedge funds holding Takeda Pharmaceutical Company’s share is Brandes Investment Partners LP. It holds Takeda Pharmaceutical Company’s shares valued at 40M.
---
Takeda Pharmaceutical Company Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.00 (49.37% Upside)
$20.00 (49.37% Upside)
Blogger Sentiment
Bullish
TAK Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 499.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 1.3%
Last 30 Days ▲ 1.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.79%
12-Months-Change
Fundamentals
Return on Equity
2.11%
Trailing 12-Months
Asset Growth
-4.81%
Trailing 12-Months
Company Description
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited is engaged in the research and development, manufacturing, marketing, and importing and exporting of pharmaceutical drugs and other healthcare products. The company offers pharmaceutical products in the areas of oncology, neuroscience, gastroenterology, and rare diseases.
---
TAK Company Deck
---
TAK Earnings Call
Q4 2024
0:00 / 0:00
---
TAK Stock 12 Month Forecast
Average Price Target
$20.00
▲(49.37% Upside)
Technical Analysis
Best Analysts Covering TAK
1 Year
1 Year Success Rate
0/4 ratings generated profit
1 Year Average Return
-12.55%
reiterated a buy rating 8 months ago
Copying Koichi Mamegano's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -12.55% per trade.
---